Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022

Stock Price vs Company Growth
1d
2.8%
1w
1.7%
1m
17.3%
3m
19.4%
6m
27.8%
1y
9.1%
all
3.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 211 2.8%
158
218
Company Overview

Sales
9,205 Cr
Growth: 0.1%
Profit after Tax
-314 Cr
Growth: -9.5%
Mid Cap
28,032 Cr
P/S: 3.0x
Industry P/S: 2.7x
Fundamentals

Sales (Cr) ₹ 9,205
Growth 0.1%
EBITDA 11.0%
P/S 3.0x
Dividend 0.1%
P/E -88.4x
Book Value ₹ 60.8
PEG Ratio -1240.8x
ROE -3.9%
P/B 3.4x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the India’s largest Pharmaceutical Company. PPL offers a portfolio of differentiated products and services through its global development and manufacturing facilities and a global distribution network in various countries.
Investors (6)
Followers (2)